• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Disease activity is associated with spinal radiographic progression in axial spondyloarthritis independently of exposure to tumour necrosis factor inhibitors.

作者信息

Sepriano Alexandre, Ramiro Sofia, Wichuk Stephanie, Chiowchanwisawakit Praveena, Paschke Joel, van der Heijde Désirée, Landewé Robert, Maksymowych Walter P

机构信息

Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.

NOVA Medical School, Universidade Nova de Lisboa, Lisboa, Portugal.

出版信息

Rheumatology (Oxford). 2021 Jan 5;60(1):461-462. doi: 10.1093/rheumatology/keaa564.

DOI:10.1093/rheumatology/keaa564
PMID:33118014
Abstract
摘要

相似文献

1
Disease activity is associated with spinal radiographic progression in axial spondyloarthritis independently of exposure to tumour necrosis factor inhibitors.在轴性脊柱关节炎中，疾病活动与脊柱影像学进展相关，且独立于肿瘤坏死因子抑制剂的使用情况。
Rheumatology (Oxford). 2021 Jan 5;60(1):461-462. doi: 10.1093/rheumatology/keaa564.
2
Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors.依奇珠单抗治疗影像学轴向型脊柱关节炎的疗效和安全性：在先前对肿瘤坏死因子抑制剂反应不足或不耐受的患者中进行的一项为期 16 周的 III 期随机、双盲、安慰剂对照试验的结果。
Arthritis Rheumatol. 2019 Apr;71(4):599-611. doi: 10.1002/art.40753. Epub 2019 Mar 8.
3
The effect of tumour necrosis factor inhibitors on radiographic progression in axial spondyloarthritis: a systematic literature review.肿瘤坏死因子抑制剂对轴性脊柱关节炎放射学进展的影响：系统文献回顾。
Rheumatology (Oxford). 2019 Nov 1;58(11):1907-1922. doi: 10.1093/rheumatology/kez363.
4
Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis.基线放射学损伤、急性期反应物水平升高和吸烟状况可预测早期中轴型脊柱关节炎的脊柱放射学进展。
Arthritis Rheum. 2012 May;64(5):1388-98. doi: 10.1002/art.33465.
5
Progression of Structural Damage in the Sacroiliac Joints in Patients With Early Axial Spondyloarthritis During Long-Term Anti-Tumor Necrosis Factor Treatment: Six-Year Results of Continuous Treatment With Etanercept.抗肿瘤坏死因子治疗的早期中轴型脊柱关节炎患者骶髂关节结构损伤的进展：依那西普持续治疗 6 年的结果。
Arthritis Rheumatol. 2019 May;71(5):722-728. doi: 10.1002/art.40786. Epub 2019 Mar 7.
6
Comment on: Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.关于《一线肿瘤坏死因子抑制剂在影像学和非影像学轴向脊柱关节炎中的不同药物生存率：一项多中心回顾性调查》的评论
Clin Exp Rheumatol. 2020 Sep-Oct;38(5):1033. Epub 2020 Feb 14.
7
Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.肿瘤坏死因子α抑制剂在影像学和非影像学轴向脊柱关节炎中的应用：一项大型观察性队列研究结果
Arthritis Rheum. 2013 Dec;65(12):3096-106. doi: 10.1002/art.38140.
8
The Effect of TNF Inhibition on Bone Density and Fracture Risk and of IL17 Inhibition on Radiographic Progression and Bone Density in Patients with Axial Spondyloarthritis: a Systematic Literature Review.TNF 抑制剂对骨密度和骨折风险的影响，以及 IL17 抑制剂对轴性脊柱关节炎患者影像学进展和骨密度的影响：系统文献回顾。
Curr Rheumatol Rep. 2019 Mar 12;21(5):20. doi: 10.1007/s11926-019-0818-9.
9
Are the recommendations for the use of anti-TNF drugs during axial spondyloarthritis relevant for non-radiographic forms?对于非放射学表现的中轴型脊柱关节炎，使用抗TNF药物的建议是否适用？
Joint Bone Spine. 2020 Oct;87(5):381-383. doi: 10.1016/j.jbspin.2020.02.007. Epub 2020 Mar 5.
10
Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohort.与早期轴性脊柱关节炎放射学病变相关的因素。来自 DESIR 队列的结果。
Rheumatology (Oxford). 2013 Sep;52(9):1686-93. doi: 10.1093/rheumatology/ket207. Epub 2013 Jun 13.

引用本文的文献

1
Comparison of Ankylosing Spondylitis Disease Activity Score and Bath Ankylosing Spondylitis Disease Activity Index tools in assessment of axial spondyloarthritis activity.强直性脊柱炎疾病活动评分与巴斯强直性脊柱炎疾病活动指数工具在评估轴性脊柱关节炎活动度中的比较。
Reumatologia. 2024;62(1):64-69. doi: 10.5114/reum/185429. Epub 2024 Mar 18.
2
How to Monitor Disease Activity of Axial Spondyloarthritis in Clinical Practice.如何在临床实践中监测中轴型脊柱关节炎的疾病活动度。
Curr Rheumatol Rep. 2024 May;26(5):170-177. doi: 10.1007/s11926-024-01141-0. Epub 2024 Feb 19.
3
Chemical Shift-Encoded MRI of Bone Metabolic Markers in Ankylosing Spondylitis.
磁共振化学位移编码技术在强直性脊柱炎骨代谢标志物检测中的应用
Dis Markers. 2022 Oct 13;2022:1846667. doi: 10.1155/2022/1846667. eCollection 2022.
4
Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain.推荐的治疗目标在接受生物治疗的中轴型脊柱关节炎患者中的实现率和预测因素：西班牙的一项前瞻性队列研究。
BMJ Open. 2022 Apr 29;12(4):e057850. doi: 10.1136/bmjopen-2021-057850.
5
The Need for SPACE to Plan the Future for Spondyloarthritis.为脊柱关节炎规划未来需要空间。
J Rheumatol. 2022 Apr;49(4):341-342. doi: 10.3899/jrheum.211212. Epub 2021 Dec 15.
6
Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inference.生物制剂 DMARDs 和中轴型脊柱关节炎的疾病修饰：因果推理视角下的综述。
RMD Open. 2021 Jul;7(2). doi: 10.1136/rmdopen-2021-001654.
7
Tumor Necrosis Factor Inhibitors Reduce Spinal Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: A Longitudinal Analysis From the Alberta Prospective Cohort.肿瘤坏死因子抑制剂可降低影像学轴向型脊柱关节炎患者的脊柱影像学进展：艾伯塔省前瞻性队列的纵向分析。
Arthritis Rheumatol. 2021 Jul;73(7):1211-1219. doi: 10.1002/art.41667. Epub 2021 May 25.